Importation
Drug importation will “jeopardize the health and well-being of millions of Americans,” Pacific Research Institute CEO warns
In this
A Colorado Woman Was Seriously Ill. No One Suspected Her Imported Drugs.
In this February 4th, 2019 editorial for Colorado Politics, Denver resident Ali Schroer warns, “I experienced firsthand the dangers of counterfeit, imported drugs, and was critically ill for months as we sought to uncover the source of my illness.”
[...]Partnership For Safe Medicines 2019 Congressional Briefings
On Thursday, January 31, 2019, victims of counterfeit medicines and their families, local law enforcement, former DEA agents, and other experts in the fight against counterfeit medicines met for a discussion about the widespread impact fake drugs are having on communities and on the enormous burden the problem places on regulators who are responsible for our drug safety.
Learn more and watch the briefing here.
[...]Importation is “extremely dangerous idea,” says former FBI Director Freeh
In this editorial, which first appeared in The Washington Times on January 29, 2019, former FBI Director Louis J. Freeh revisits the problem drug importation poses to law enforcement and regulatory systems already overburdened by the opioid crisis.
[...]National Association of Manufacturers Exec warns, “Importation Proposals Disguise Serious Risks”
In this January 30, 2019 editorial, which was published in the National Association of Manufacturer’s Shopfloor blog, Vice President of Infrastructure Robyn Boerstling warns that even though legislators have good intentions, importation could “result in disastrous outcomes.”
[...]Importation Is Too Risky, Warns Former FDA Associate Commissioner
In a January 23, 2019 editorial published in The Hill Peter Pitts, a former FDA associate commissioner and the president of the Center for Medicine in the Public Interest, explains why the safety risks of importation far outweigh any savings.
[...]Partnership for Safe Medicines’ Statement on New Drug Importation Bills
Washington, D.C. (January 10, 2019) – Marv Shepherd, President of the Partnership for Safe Medicines, released the following statement today in response to new legislation, the “Affordable and Safe Prescription Drug Importation Act,” and the “Safe and Affordable Drugs from Canada Act of 2019” which would allow medicines to be imported into the United States…
[...]Side Stepping FDA Safeguards to Buy Medicine in Mexico Isn’t Safe, Former DEA Agents Warn
In this editorial, which was published in The Salt Lake Tribune on December 10, 2018, former DEA agents Javier Peña and Steve Murphy, warn that importing prescription drugs from other countries is “an extremely risky enterprise with potentially tragic consequences.”
[...]Former Ontario Police Superintendent Warns That Gang-Backed Fentanyl Trafficking Threatens both Canada and the U.S.
In this editorial, which appeared in Inside Sources on November 20, 2018, former chief superintendent of the Ontario Provincial Police Don Bell discusses the threat that gang-backed fentanyl trafficking poses to the U.S. and Canada, and emphasizes the importance of working together to secure the border.
[...]Mexican Pharmacies Are Not The Best Place For Medicare Recipients To Lower Their Prescription Costs
Some seniors who winter in the south cross the border to purchase prescription drugs in Mexico, frequently citing the savings. With counterfeit drugs being an issue acknowledged by Mexico’s government, Americans need to know that there are better savings to be found here in the U.S. They just need to ask their pharmacist…
[...]